Navigation Links
Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
Date:1/7/2009

SEATTLE, Jan. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that they received $7.5 million pursuant to the joint venture transaction with Spectrum Pharmaceuticals, Inc. to commercialize and develop Zevalin(R) in the United States. In December, the Company received the initial $7.5 million payment in connection with the closing of such transaction. The Company may earn up to an additional $15 million in product sales milestone payments upon achievement of certain revenue targets.

Zevalin, a radioimmunotherapeutic, was exclusively marketed by CTI in the United States since December, 2007 and is now marketed jointly by CTI and Spectrum through RIT Oncology, LLC ("RIT") for the treatment of patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL), including patients who have rituximab-refractory follicular NHL. CTI holds a sale option exercisable from January 15, 2009 through July 15, 2009 in its sole discretion to sell its 50% membership interest in RIT to Spectrum for $18 million. The FDA has accepted for filing and review, and has granted priority review status for a supplemental Biologics License Application (sBLA) for use of Zevalin as consolidation therapy in patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy and expects a decision regarding the sBLA in early April, 2009.

About Zevalin(R)

Zevalin(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the Zevalin therapeutic regimen for treatment of relapsed or refractory, lowgrade or follicular B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular NHL. Zevalin is also indicated, under accelerated approval, for the treatment of relapsed or refractory, rituximab-naive, low-grade and follicular NHL based on studies using a sur
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... May 18, 2013 Spectrum Surgical ... on May 17-22 in Austin, TX where thousands ... educational and networking opportunities. , Spectrum Surgical/STERIS ... flexible scope repair capabilities and certified pre-owned ... educational information on proper instrument care of flexible ...
(Date:5/18/2013)... The topics that will be covered in the 1-day Agile ... scrum artifacts, and scrum simulation (optional). One can earn eight ... trainings are suitable for business analysts, project managers, developers, testers, ... be a part of the Scrum team, people outside the ... Scrum, but are unsure of what it is. , ...
(Date:5/18/2013)... 2013 Wine World Accessories, a renowned ... customers an attractive 25% discount on Franmara Dynamo ... can now purchase this electric corkscrew opener for $44.95 ... process. The online store ensures delivery of their items ... placement. , A spokesperson from the online store ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Medical device company, ... for its much anticipated mobility aid with its namesake, the ... a hands-free crutch alternative that injured individuals can ... ankle, for example, can remain active and walk during a ... using its reservation system to ensure those who need the ...
Breaking Medicine News(10 mins):Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:FlexLeg Begins Offering New Mobility Aid 2
... findings show how it may be possible to render cancer tumours ... The findings apply to cancers including breast, lung and bowel cancer. ... Many of the most common chemotherapy drugs used to treat cancer ... in the cancer tumour, but also the cells in the rest ...
... a vaginal gel to protect themselves against HIV infection? Researchers ... question when it comes to developing products known as microbicides ... Now the findings of a new study known as ... topical vaginal gels information that could be used to ...
... Having a new baby brings much joy to a new family. ... end, fusses through feedings, or has difficulty sleeping, the joy may ... of that infant and that family will impact the ... published in the Infant Mental Health Journal that supports ...
... (UC) have found that a certain cellular pathway ... disease and fatty liver disease. These findings, ... Thrombosis and Vascular Biology (ATVB) 2012 Scientific Sessions ... a potential molecular target for metabolic diseases in ...
... can expect to live without disability. It has been computed ... 2005. These figures are released in the framework of the ... Life Years (EHLEIS), organized in Paris on April 19, 2012 ... French Ministry of Health. The European Joint Action on Healthy ...
... shortfall in funding for emergency laparotomies in England and have ... picture of outcomes and costs. Figures published in the May ... million per year for emergency midline general surgical laparotomies, 32% ... also found that emergency laparotomy, which involves a large midline ...
Cached Medicine News:Health News:Possible new cancer treatment identified 2Health News:Will women use microbicides to protect themselves against HIV? 2Health News:Will women use microbicides to protect themselves against HIV? 3Health News:Research shows efficacy of treatment model developed at Women & Infants 2Health News:Cellular pathway linked to diabetes, heart disease 2Health News:Life expectancy and healthy life years in the European Union, 2008-2010 2Health News:Life expectancy and healthy life years in the European Union, 2008-2010 3Health News:Study reveals major funding shortfall and high death rates for emergency laparotomy 2Health News:Study reveals major funding shortfall and high death rates for emergency laparotomy 3
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology ... Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting ... which will be held at the San ... Diego, California , from May 20 - 22.  ... second analytical system, incorporating commercial audio-visual technologies into new ...
(Date:5/17/2013)... , May 17, 2013 ... health economics and outcomes research also   to   ... NASDAQ: SHPG ), the global specialty biopharmaceutical ... 7 poster presentations at the American Psychiatric Association (APA) ... , May 18-22. The data being presented represent Shire,s ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... Healthcare Products, Inc., (NASDAQ: AHPI ) reported ... hospitals and government entities still suffering from recession-driven budget cuts. ... per basic and diluted share, for the 2011 fiscal year compared ... per share, for the previous year. For the quarter, ...
... Sept. 2, 2011 Sigma-Aldrich Corporation (NASDAQ: ... conferences in September: KeyBanc Capital Markets ... 13, at the InterContinental, Boston, MA, presenting at 9:00 ... Wednesday, September 14, at the Grand Hyatt, New York, ...
Cached Medicine Technology:Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession 2Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession 3Allied Healthcare Reports Profitable Quarter and Year Despite Lingering Effects of Recession 4Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2
... simplified operations, the Sysmex KX-21N is ... satellite lab testing. This 3-part ... Built on the reliable, field ... features a completely automatic START-UP function ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
... Inverness Medical Ovulation Test Kits help you plan ... predictor sticks to help you predict your most ... quickly and accurately detect the increase in luteinizing ... occurs 24 to 48 hours before ovulation. You ...
Medicine Products: